Trials
AI-powered patient identification to accelerate clinical trial enrollment and discovery.
Executive Summary
Tempus AI's "Trials" solution is a cutting-edge platform designed to significantly accelerate and optimize clinical trial enrollment for pharmaceutical companies, life sciences organizations, and research institutions. By leveraging advanced artificial intelligence, the platform aims to streamline the complex process of identifying and matching eligible patients to clinical studies, thereby speeding up the discovery of novel treatments and improving patient access to potentially life-saving therapies. The core of the "Trials" solution lies in its powerful AI engine, which analyzes vast amounts of both structured and unstructured clinical data, including comprehensive electronic health records (EHRs), electronic medical records (EMRs), and molecular profiling data. This deep analysis allows the system to interpret complex patient profiles against specific trial inclusion and exclusion criteria, enabling precise patient identification and cohort sizing. The platform also features an AI assistant, Tempus One, powered by large language models, to facilitate interactive querying and discovery. Through its intelligent matching capabilities, Tempus AI's "Trials" not only enhances the efficiency of patient recruitment but also contributes to substantial cost savings for trial sponsors. It provides intuitive tooling and dashboards for visualizing patient cohorts and managing trial portfolios, ensuring that the right patients are connected with the right trials more quickly and effectively. This precision medicine approach ultimately helps activate more trials and drives forward the development of personalized healthcare solutions.
Use Cases
- Accelerating patient identification and enrollment for clinical trials.
- Optimizing clinical trial design and feasibility by identifying suitable patient cohorts.
- Reducing the time and cost associated with trial recruitment.
- Matching patients to potentially life-saving clinical trials based on their unique clinical profiles.
- Leveraging real-world data to inform trial selection and patient screening.
Features
Visibility
- Patient Cohort Visualization: Tools to easily size and visualize patient cohorts based on specific criteria for trial feasibility.
- Trial Portfolio Management: Interface to manage and explore a broad portfolio of clinical trials and their matching requirements.
Intelligence
- AI-Powered Patient Matching: Utilizes AI to analyze comprehensive clinical data for precise patient identification and matching to relevant trials.
- Real-World Data Insights: Leverages real-world data to enhance trial matching accuracy and provide insights into patient populations.
- Generative AI Assistant (Tempus One): An LLM-powered assistant to facilitate interactive querying and discovery of patient cohorts.
Technical Specifications
- Architecture
- Cloud-native, AI-driven platform leveraging large language models (LLMs) and machine learning for processing and analyzing complex clinical and genomic data.
- Deployment
- SaaS
- API Available
- Yes
AI/ML Stack
- Machine Learning
- Large Language Models (LLMs)
Integrations
- EHR Systems
- EMR Systems
Pricing
- Model
- Subscription-based for enterprise clients
- Starting Price
- Contact sales
- Target Customer
- Enterprise,Pharmaceutical Companies,Life Sciences Organizations,Research Institutions
About Tempus AI
Tempus AI is a healthcare technology company that leverages data and artificial intelligence to provide precision medicine services, including diagnostics, for various therapeutic areas such as oncology, cardiology, radiology, and depression. The company has built one of the world's largest libraries of clinical and molecular data, along with an operating system to make this data accessible and useful for personalized patient care and accelerating therapeutic discovery.